- Home
- USCB vs ANGO Comparison
USCB vs ANGO Comparison
Compare USCB & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$12.89
Company Overview
Basic Information| Metric | USCB | ANGO |
|---|---|---|
| Founded | 2002 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 346.8M | 550.8M |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | USCB | ANGO |
|---|---|---|
| Price | $18.76 | $12.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $22.00 | $19.33 |
| AVG Volume (30 Days) | 46.5K | ★ 417.7K |
| Earning Date | 01-22-2026 | 01-06-2026 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | ★ 50.85 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | $92,331,000.00 | ★ $300,718,000.00 |
| Revenue This Year | $26.31 | $8.18 |
| Revenue Next Year | $15.23 | $5.15 |
| P/E Ratio | $11.93 | ★ N/A |
| Revenue Growth | ★ 28.61 | 2.73 |
| 52 Week Low | $15.39 | $8.27 |
| 52 Week High | $20.49 | $13.99 |
Technical Indicators
Market Signals| Indicator | USCB | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 48.96 |
| Support Level | $18.88 | $13.12 |
| Resistance Level | $19.95 | $13.91 |
| Average True Range (ATR) | 0.60 | 0.37 |
| MACD | -0.09 | -0.09 |
| Stochastic Oscillator | 12.03 | 5.71 |
Price Performance
Historical Comparison USCB
ANGO
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.